Minoxidil Cinfa

Minoxidil, the active ingredient in Minoxidil Cinfa, is a potassium channel opener presented as a topical solution for topical use. It treats androgenetic alopecia and other forms of hair loss in adults.

GNH USA supplies Minoxidil Cinfa as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil acts on the hair‑growth cycle and is indicated for conditions that cause patterned hair loss. - Androgenetic alopecia: promotes regrowth of scalp hair in men and women. - Female pattern hair loss: stimulates new hair growth on the crown and frontal scalp. - Telogen effluvium: may accelerate the return of normal hair growth after shedding episodes.

Topical minoxidil can cause local and systemic reactions.

Common Side Effects: - Scalp irritation: itching, burning, or stinging at the application site. - Dryness or flaking of the scalp skin. - Redness or erythema of the treated area. - Unwanted facial hair growth (hypertrichosis). - Contact dermatitis: allergic skin reaction. - Temporary shedding of existing hair during early treatment.

Serious or Rare Side Effects: - Severe allergic reaction: swelling of face, lips, or tongue. - Chest pain or palpitations indicating systemic absorption. - Rapid heart rate (tachycardia) or low blood pressure. - Dizziness or fainting episodes. - Unexplained weight gain due to fluid retention.

Before using Minoxidil Cinfa, consider the following safety measures. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown safety; consult a healthcare professional. - Cardiovascular disease: monitor blood pressure and heart rate. - Concurrent topical products: assess for increased irritation. - Application: use on dry scalp, avoid eyes and mucous membranes, wash hands after use. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Minoxidil may interact with other medications or topical agents.

Major Interactions (Avoid): - Oral minoxidil: additive systemic vasodilatory effect. - Antihypertensive drugs: risk of excessive hypotension. - Other potassium channel openers: increased cardiovascular effects.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may enhance minoxidil absorption. - Hair dyes or chemical treatments: can increase scalp irritation.